Searched for
ANTIBODY RESPONSE
Doctors said father’s kidney transplant was difficult. Still, his 18-year-old son, fresh off scoring 92% in Class 12, donated a kidney and made the impossible happenA remarkable Father's Day story unfolds as 18-year-old Ali donated a kidney to his father, Abid Raza, who was battling severe kidney failur...- Ebola cases increase almost 40% in week as death toll passes 200An Ebola outbreak in Congo and Uganda has claimed over 200 lives. This is the worst outbreak at this stage, with thousands of potential con...
- First AI-designed 'universal vaccine' tested in humans: UK researchersA groundbreaking vaccine, designed entirely by artificial intelligence, has been tested in humans for the first time. This experimental jab...
- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
- What to know about the Bundibugyo virus, a species of Ebola causing an outbreak in CongoA rare Bundibugyo virus outbreak in Congo, with over 200 deaths, lacks specific treatments or vaccines, complicating response efforts. Whil...
- Ebola vaccine update: Russia claims a breakthrough; Oxford researchers, Serum Institute of India aim to begin trial in 3 monthsA new Ebola vaccine developed by Russian scientists shows promise against the current outbreak strain in the Democratic Republic of Congo. ...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsGiven the latest news flow from the Gulf region, the probability is high that we might once again see the bulls attempting a comeback. As u...
- Hantavirus scientists were close to vaccine but ran out of moneyScientists in Chile developed antibodies that successfully neutralised the deadly Andes hantavirus in lab and animal studies, raising hopes...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- Hantavirus cruise ship outbreak: What is Andes strain? Symptoms, mortality rate, treatment, vaccines and all details you need to knowHantavirus Andes strain update: A deadly Andes strain hantavirus outbreak linked to the MV Hondius cruise ship has resulted in three deaths...
- Lord’s Mark among few global players to win HIV self-test approval, exports from June 2026Lord's Mark Industries Ltd. has secured Central Licensing Authority approval for its LordsMed HIV 1&2 Self Test, becoming one of nine globa...
- Covaxin third jab boosts antibody response against several Covid strains: StudyBharat Biotech said the “comprehensive” study has demonstrated multiple benefits of its vaccine, including long-term immune response, cell-...
- Mix & Match of Covaxin, Covishield elicits four times antibody response: StudyThe findings are particularly important when considering administering third booster dose aiming to elicit robust antibody response and hel...
- Antibodies from earlier Covid strain may not help fight variantsThe finding has implications for the ability of new variants to reinfect people who contracted earlier versions of the virus.
- Elderly show equally strong antibody response to first dose of AstraZeneca, Pfizer COVID-19 shotsThe study also found, however, that a critical component of the immune system known as T cells showed a more enhanced response in those who...
- COVID-19 recovered people showing faster antibody response to Covishield vaccine: StudyThe study on the immune response to Covishield was carried out by researchers from New Delhi's CSIR-Institute of Genomics and Integrative B...
- Covid vaccines work better in recovered individuals: StudyThe study, which has not been peer-reviewed and was pre-printed by medRxiv on February 1, reveals that the antibody response generated by t...
- COVID-19 triggers antibodies from previous coronavirus infections, says study"Our results suggest that the COVID-19 virus may awaken an antibody response that existed in humans prior to our current pandemic, meaning ...
- Asymptomatic Covid patients likely to lose antibodies sooner, says studyThe findings also suggest the loss of antibodies was slower in 18-24 year-olds compared to those aged 75 and over.
- Antibody immunity to novel coronavirus may be short-lived: UK studyPatients who recover from the novel coronavirus may have an antibody response that makes them immune to the deadly virus only for a few mon...
Load More
